Volume 3, Issue 5
Editorialp. 403
Recent advances in the genetics of ankylosingspondylitis
Author(s): Muhammad Asim Khan
Editorialp. 407
Vitamin D and response to treatment in postmenopausal osteoporosis
Author(s): Silvano Adami
Bulletin Boardp. 409
Adalimumab may be an effective treatment for juvenile rheumatoid arthritis
Author(s): News and Event
Drug Evaluationp. 421
Febuxostat, a novel drug for the treatment of hyperuricemia of gout
Author(s): Fernando Perez-Ruiz
Commentaryp. 429
The OPTION trail: inhibition of the interleukin-6 receptor with tocilizumab in patients with rheumatoid arthritis
Author(s): Cesar Ramos-Remus
Priority Paper Evaluationp. 435
Anti-TNF drugs in ankylosing spondylitis: the present and future
Author(s): Andrei Calin
Priority Paper Evaluationp. 437
Heart failure in patients with rheumatoid arthritis is clinically different and has a worse prognosis
Author(s): Mario H Cardiel
Priority Paper Evaluationp. 441
Predicting the development of rheumatoid arthritis in patient with recent-onset undifferentiated arthritis
Author(s): Paul Emery
Special Issue Articlep. 445
Perspective on the risks of infection and malignancy with rheumatoid arthritis therapy
Author(s): Marie Hudson
Review Articlep. 451
Contribution of total knee arthroplasty to increased bone mineral density
Author(s): Yoshikazu Matsuda
Review Articlep. 457
Ankylosing spondylitis and other spondyloarthropathies: extra-articular manifestations and their management
Author(s): Alejandro Escudero-Contreras
Review Articlep. 475
Heart rate variability as a biomarker of fibromyalgia syndrome
Author(s): Roland Staud
Bulletin Boardp. 503
Tocilizumab found to be effective replacement for anti-TNF therapy in rheumatoid arthritis
Author(s): News and Event
